IVD News and Research

RSS

Tecan Synergence offers comprehensive approach to OEM system development

Tecan Partnering has consolidated its extensive OEM system development services for life sciences and IVD instruments to create Tecan Synergence™. Bringing together over 40 years of experience in laboratory automation and OEM instrument development, Tecan Synergence provides a rapid, structured and flexible approach to the creation of OEM solutions, shortening time to market and reducing project risk.

From Tecan 29 Aug 2019

Beckman Coulter Life Sciences publishes ClearLLab Control Cells white paper

Beckman Coulter Life Sciences has published a flow cytometry white paper to support the gating strategies behind its newly launched IVD ClearLLab Control Cells.

From Beckman Coulter Life Sciences - Flow Cytometry 6 Aug 2019

Maetrics' new whitepaper highlights regulatory changes and challenges for combination product manufacturers

Maetrics, a leading international life sciences regulatory and compliance consultancy, has launched a new whitepaper on the adaptations and additions to the EU Medical Device Regulation pertaining to drug device combination products.

25 Jul 2019

OGT expands SureSeq NGS portfolio with a complete library preparation solution

Oxford Gene Technology (OGT), The Molecular Genetics Company, has expanded its SureSeq portfolio with a complete library preparation solution for hybridization-based target capture in NGS, making its market-leading coverage uniformity and expertise even more accessible.

From Oxford Gene Technology 13 Jun 2019

Spotlight on ECCMID 2019: Detecting Disease & Managing Infections

This article covers some of the highlights of ECCMID 2019, with insights into some of the companies and products being featured at the event.

From ESCMID 15 Apr 2019

BD receives CE-IVD certification for new flow cytometry sample preparation system

BD, a leading global medical technology company, today announced the CE-IVD certification for the BD FACSDuet automated flow cytometry system.

29 Mar 2019

Improved TB Diagnostic Assay for Better Multiplexing from Bruker

In time for the World Tuberculosis (TB) Day 2019 on Sunday, March 24th, Bruker today announced the launch of an important further innovation in the field of tuberculosis diagnostics.

From Bruker BioSpin - NMR, EPR and Imaging 26 Mar 2019

TGen and ABL sign agreement to distribute new TB test technology

n an important step toward eradicating tuberculosis, the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, has signed a licensing agreement with an international biomedical firm, Advanced Biological Laboratories, to market and distribute TGen's patented Next Generation Sequencing-based TB test technology.

19 Mar 2019

Quanterix corporation releases operating results for fourth quarter and full year 2018

Quanterix announced financial results for the three months and twelve months ended Dec. 31, 2018.

From Quanterix 7 Mar 2019

GenoScreen’s Deeplex-MycTB test could help define appropriate treatment for tuberculosis patients

The new Deeplex®-MycTB mycobacterial antibiotic resistance test1, developed by GenoScreen, has been used by an international research team in a molecular epidemiology study published in The Lancet Infectious Diseases.

13 Feb 2019

FDA grants clearance to Hologic’s assay for detection of common sexually transmitted infections

Hologic, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted clearance for its Aptima Mycoplasma genitalium assay, the first and only FDA-cleared test to detect this under-recognized but increasingly common sexually transmitted infection (STI).

23 Jan 2019

Beckman Coulter launches new ClearLLab 10C System for clinical flow cytometry lab

Beckman Coulter launches the ClearLLab 10C System - the first 10-colour CE-IVD panels of immunophenotyping reagents for lymphoid and myeloid lineages.

From Beckman Coulter Life Sciences - Flow Cytometry 17 Jan 2019

DIACARTA introduces new QClamp assays for detection of cancer gene mutations

DIACARTA Inc., a precision molecular diagnostics company headquartered in Richmond, California, today announced that it is launching a new suite of CE-IVD marked highly sensitive hydrolysis probe based QClamp assays for detection of common cancer mutations in genes, such as KRAS, NRAS, BRAF, EGFR, PIK3CA and JAK2, using tissue biopsyand liquid biopsy samples.

29 Oct 2018

New RenataDX Screening System launched for clinical laboratories

Waters Corporation introduced the RenataDX Screening System, a flow-injection tandem mass spectrometry system for rapid high-throughput analysis of extracted dried blood spots and other human biological matrices.

10 Oct 2018

New study demonstrates tissue regenerative potential of chemoattractant delivery system

A new study has demonstrated the tissue regenerative potential of a chemoattractant delivery system that can draw mesenchymal stem cells (MSCs) to the site of intervertebral disc (IVD) degeneration.

5 Sep 2018

Image Cytometry Technology and Tissue Analysis

Image cytometry or tissue cytometry, not only measures the size, diameter and shape of a cell, but quantifies the molecular marker expression.

From TissueGnostics 4 Sep 2018

Beckman Coulter offers largest range of single color CE-IVD and ASR conjugated antibodies

Beckman Coulter Life Sciences now offers its largest portfolio of single color CE-IVD and ASR (analyte-specific reagent) conjugated antibodies.

From Beckman Coulter Life Sciences - Flow Cytometry 30 Jul 2018

Beckman Coulter introduces expanded range of clinical flow cytometry solutions at AACC 2018

Beckman Coulter continues to expand portfolio of clinical flow cytometry solutions with its latest innovations.

From Beckman Coulter Life Sciences - Flow Cytometry 30 Jul 2018

Philips and Oxford University Hospitals NHS Foundation Trust join hands to set up digital pathology network

Royal Philips, a global leader in health technology, and Oxford University Hospitals (OUH) NHS Foundation Trust, today announced plans to create a digital pathology network to help drive faster and more efficient diagnoses for patients.

From Philips Healthcare 27 Jul 2018

Co-Diagnostics obtains CE mark approval for Logix Smart MTB Test

Co-Diagnostics, Inc., a molecular diagnostics company with a unique, proprietary platform for the development of molecular diagnostic tests, announced today that its Logix Smart™ MTB Test has obtained CE mark approval, the principle regulatory clearance allowing the test to be sold as an in vitro diagnostic for the diagnosis of tuberculosis in European Union states and other markets that accept a CE-IVD mark as valid regulatory approval.

25 Jul 2018